The multiple endocrine neoplasia syndromes form a distinct group of genetic
tumor syndromes. They include multiple endocrine neoplasia types 1 and 2,
von Hippel Lindau syndrome, neurofibromatosis, and Carney complex. Research
over the past decade has identified a molecular basis for each of these sy
ndromes. This knowledge has revolutionized not only the clinical management
but also has illuminated the field of human cancer research by the identif
ication of new and important genes critical for regulation of cell growth,
differentiation, and death. This review focuses on the structure, physiolog
ic function, and molecular abnormalities of the genes involved in these syn
dromes.